Axsome Therapeutics, Inc.

New York, New York, United States axsome.com

Overview

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company's mission is to improve the lives of people living with certain underserved conditions through innovative clinical research. Axsome leverages its experience to develop and commercialize new treatment options that address significant unmet medical needs.

Therapeutic areas

Central Nervous System DisordersDepressionMigraineNarcolepsyAlzheimer's Disease Agitation

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Axsome Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Naurex, Inc.
USA
Acadia Pharmaceuticals Inc.
United States
AnxiClear Pharmaceuticals Inc.
USA
ArmaGen, Inc.
USA
Astex Pharmaceuticals, Inc.
United States
Cerevel Therapeutics Holdings, Inc.
United States
Gilgamesh Pharmaceuticals
United States
Impax Laboratories, LLC
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo